The low binding affinity of ADAMTS4 for citrullinated fibronectin may contribute to the destruction of joint cartilage in rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 31, Issue 2, 2013, Pages 0201-0206

  Yan, Xinfeng ^a   Yin, Luxu ^a   Wang, Yuejian ^b   Zhao, Yan ^b   Chang, Xiaotian ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

ADAMTS4; Citrullination; Fibronectin; Joint cartilage destruction; PADI4; Rheumatoid arthritis

Indexed keywords

AGGRECANASE 1; ALANYLARGINYLGLYCYLSERYLVALYLISOLEUCYLLEUCINE; CITRULLINATED FIBRONECTIN; FIBRONECTIN; PEPTIDE; UNCLASSIFIED DRUG; ADAM PROTEIN; AGGRECAN; AGGRECANASE-1; CITRULLINE; HYDROLASE; PEPTIDYLARGININE DEIMINASE TYPE IV; PROCOLLAGEN N PROTEINASE; RECOMBINANT PROTEIN;

ARTICLE; BINDING AFFINITY; CARTILAGE DEGENERATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN MODIFICATION; RHEUMATOID ARTHRITIS; ARTICULAR CARTILAGE; CELL STRAIN HEK293; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; JOINT; METABOLISM; PATHOLOGY;

ADAM PROTEINS; AGGRECANS; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CITRULLINE; FIBRONECTINS; HEK293 CELLS; HUMANS; HYDROLASES; JOINTS; PROCOLLAGEN N-ENDOPEPTIDASE; PROTEIN BINDING; RECOMBINANT PROTEINS; TRANSFECTION;

MLCS; MLOWN;

EID: 84875760553     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. NAGASE H, KASHIWAGI M: Aggrecanases and cartilage matrix degradation. Arthritis Res Ther 2003; 5: 94-103.
2. TORTORELLA MD, PRATTA M, LIU RQ et al.: Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J Biol Chem 2000; 275: 18566-73.
3. STRUGLICS A, LARSSON S, PRATTA MA, KUMAR S, LARK MW, LOHMANDER LS: Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis Cartilage 2006; 14: 101-13.
4. YAMANISHI Y, BOYLE DL, CLARK M et al.: Expression and regulation of aggrecanase in arthritis: the role of TGF-beta. J Immunol 2002; 168: 1405-12.
5. HASHIMOTO G, SHIMODA M, OKADA Y: ADAMTS4 (aggrecanase-1) interaction with the C-terminal domain of fibronectin inhibits proteolysis of aggrecan. J Biol Chem 2004; 279: 32483-91.
6. KRIEGSMANN J, BERNDT A, HANSEN T et al.: Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Rheumatol Int 2004; 24: 25-33.
7. HOMANDBERG GA, WEN C, HUI F: Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluid. Osteoarthritis Cartilage 1998; 6: 231-44.
8. SUZUKI A, YAMADA R, CHANG X et al.: Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003; 34: 395-402.
9. KANG CP, LEE HS, JU H, CHO H, KANG C, BAE SC: A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 2006; 54: 90-6.
10. HOPPE B, HAUPL T, GRUBER R et al.: Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res Ther 2006; 8: R34.
11. SUZUKI A, YAMADA R, YAMAMOTO K: Citrullination by peptidylarginine deiminase in rheumatoid arthritis. Ann N Y Acad Sci 2007; 1108: 323-39.
12. CHANG X, YAMADA R, SUZUKI A et al.: Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford) 2005; 44: 40-50.
13. CHANG X, ZHAO Y, SUN S, ZHANG Y, ZHU Y: The expression of PADI4 in synovium of rheumatoid arthritis. Rheumatol Int 2009; 29: 1411-6.
14. CHANG X, YAMADA R, SUZUKI A, KOCHI Y, SAWADA T, YAMAMOTO K: Citrullination of fibronectin in rheumatoid arthritis synovial tissue. Rheumatology (Oxford) 2005; 44: 1374-82.
15. JONES JE, CAUSEY CP, KNUCKLEY B, SLACKNOYES JL, THOMPSON PR: Protein arginine deiminase 4 (PAD4). Current understanding and future therapeutic potential. Curr Opin Drug Discov Devel 2009; 12: 616-27.
16. PETERS JH, CARSONS S, YOSHIDA M et al.: Electrophoretic characterization of species of fibronectin bearing sequences from the Nterminal heparin-binding domain in synovial fluid samples from patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 2003; 5: R329-39.
17. GAO G, WESTLING J, THOMPSON VP, HOWELL TD, GOTTSCHALL PE, SANDY JD: Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation. J Biol Chem 2002; 277: 11034-41.
18. KASHIWAGI M, ENGHILD JJ, GENDRON C et al.: Altered proteolytic activities of ADAMTS- 4 expressed by C-terminal processing. J Biol Chem 2004; 279: 10109-19.